Evidence map›Paper›PMID 36466432›Full record

ArticleCase reports in pediatrics2022

Coronavirus Disease 2019 (COVID-19) Associated Hemolytic Uremic Syndrome in a Toddler.

Kristie Searcy, Apoorva Jagadish, Patricia Pichilingue-Reto, Radhakrishna Baliga

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Atypical hemolytic uremic syndrome with aFrontiers in pediatrics · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kristie SearcyDepartment of Internal Medicine and Pediatrics, LSU Health Shreveport, Shreveport, LA, USA.ORCID https://orcid.org/0000-0002-3978-3060
Apoorva JagadishDepartment of Pediatrics, LSU Health Shreveport, Shreveport, LA, USA.ORCID https://orcid.org/0000-0002-4281-1640
Patricia Pichilingue-RetoDepartment of Pediatrics, Division of Infectious Diseases, LSU Health Shreveport, Shreveport, LA, USA.ORCID https://orcid.org/0000-0002-9142-4292
Radhakrishna BaligaDepartment of Pediatrics, Division of Nephrology, LSU Health Shreveport, Shreveport, LA, USA.ORCID https://orcid.org/0000-0003-4238-4578
Louisiana State University Health Sciences Center Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a heterogenous, predominantly pulmonary disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has resulted in catastrophic illness around the world. Thrombotic microangiopathy (TMA) is a triad of hemolytic anemia, thrombocytopenia, and end organ damage. This is present in severe cases of COVID-19 and in hemolytic uremic syndrome (HUS) commonly caused by

Identifiers

PMID36466432
PMCPMC9711990
OpenAlexW4309878794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.